MODIFIERS OF MYOCARDIAL INFARCTION ONSET
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
批准号:
2219855
负责人:
JAMES E MULLER
金额:
$48.3万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-01 至 1997-11-30
关键词:
acute disease /disorder aspirin beta antiadrenergic agent cardiovascular disorder epidemiology cardiovascular disorder prevention case history chemoprevention circadian rhythms data collection methodology /evaluation diet disease /disorder proneness /risk exercise gender difference human subject interview myocardial infarction physiologic stressor psychological stressor questionnaires stress tobacco abuse
中文摘要
这是一个修改后的竞争性续期申请进行研究
标题为“心肌梗死发作的修饰物(修饰物研究)”,
阐明急性心肌梗死(MI)的病理生理学
发病我们将利用方法学技术,50家医院
国家研究小组,以及已完成的NHLBL资助的
心肌梗死发病的决定因素研究(决定因素研究)。
修改者研究将确定增加或减少
患者对急性心肌梗塞触发因素的敏感性
以前识别的。
决定因素研究开始于1989年,在广泛传播之后不久,
接受MI发生的昼夜变化。这项研究是
开始利用最先进的流行病学技术,
确定日常活动在MI触发中的作用。的
研究人员创造了一种新的流行病学技术(病例交叉
方法),开发和测试了一个24页的面试表,
由经过培训的访问者组成的大型医院研究小组,
质量控制措施,并招募了2,000多名受试者。这
广泛的活动使决定因素研究成为
发展对急性疾病发作触发的研究领域。
决定因素研究实现了其四个具体目标。它
证明了觉醒/活动,而不是绝对的时间
白天,负责早晨的触发,繁重的工作,愤怒,
和性活动是Ml的触发因素,相对风险为6,3,
2分别,β-阻断防止触发,
觉醒/活动,久坐的生活方式显着增加
重度劳累引发心肌梗塞的相对风险。
拟议的修改量研究将回答
决定因素研究的结果。它将检验假设
关于5组因素,这些因素是
对急性MI触发的敏感性:l)药理学手段
β受体阻滞剂,阿司匹林,血管紧张素转换
酶抑制剂和雌激素的使用降低了对触发物的敏感性;
2)时间-易感性在早上不会增加,
在冬天,外源性而不是内源性的日常生活
节律决定发病; 3)传统的慢性风险因素-
糖尿病、高血压和吸烟会增加易感性,
定期锻炼可降低敏感性(除
4)性别-女性较不易受到触发;
和5)饮食因素-慢性适度饮酒和抗-
氧化剂降低易感性。
为了验证上述假设,需要进行5,700次访谈。由
1993年3月完成决定因素研究后,
面试将完成。 “的”修饰语研究的延续
我们目前每月77次面试将提供所需的3700个
1997年12月前进行更多访谈。为了保持研究
在8个月的修改研究审查期间,我们将
用有限非联邦资金支持护士面试。
拟议研究的长期目标是更全面地确定
触发发生的机制,从而促进
确定新的预防手段。虽然大多数潜在的
触发活动是不可避免的,急性MI的触发可能
通过使用药物或其他干预措施来预防,
潜在诱因与其灾难性后果之间的生理联系
后果
英文摘要
This is a revised competing renewal application to conduct a study
entitled Modifiers of Myocardial Infarction Onset (Modifiers Study) to
elucidate the pathophysiology of acute myocardial infarction (Ml)
onset. We will utilize the methodologic techniques, 50-hospital
national study group, and findings of the completed NHLBl-funded
Determinants of Myocardial Infarction Onset Study (Determinants Study).
The Modifiers Study will identify factors that increase or decrease the
susceptibility of patients to the triggers of acute Ml we have
previously identified.
The Determinants Study began in 1989, shortly after widespread
acceptance of the circadian variation in Ml occurrence. The study was
initiated to utilize state-of-the art epidemiologic techniques to
determine the role of daily activities in the triggering of Ml. The
investigators created a new epidemiologic technique (the case-crossover
method), developed and tested a 24-page interview form established a
large study group of hospitals with trained interviewers, instituted
quality control measures, and enrolled over 2,000 subjects. This
extensive activity has made the Determinants Study a centerpiece in the
developing field of research into triggering of acute disease onset.
The Determinants Study accomplished its four Specific Aims. It
demonstrated that awakening/activity, rather than the absolute time of
day, is responsible for morning triggering, that heavy exertion, anger,
and sexual activity are triggers of Ml with relative risks of 6, 3, and
2 respectively, that beta-blockade prevents triggering by
awakening/activity, and that a sedentary lifestyle markedly increases
the relative risk of triggering of Ml by heavy exertion.
The proposed Modifiers Study will answer the major questions raised by
the results of the Determinants Study. It will test hypotheses
concerning 5 groups of factors that are potential modifiers of
susceptibility to the triggering of acute MI: l) Pharmacologic means
of Prevention - that beta blockers, aspirin, angiotensin converting
enzyme inhibitors and estrogen use decrease susceptibility to triggers;
2) Timing - that susceptibility does not increase in the morning but
does in the winter, and that exogenous rather than endogenous daily
rhythms determine onset; 3) Traditional chronic risk factors - that
diabetes, hypertension, and smoking increase susceptibility and that
regular exercise decreases susceptibility (to triggers other than
exertion); 4) Gender - that women are less susceptible to triggering;
and 5) Dietary factors - that chronic moderate alcohol use and anti-
oxidants decrease susceptibility.
To test the above hypotheses, 5,700 interviews are needed. By the
completion of the Determinants Study in March 1993, over 2,000
interviews will be complete. Continuation in the Modifiers Study of
our current 77 interviews per month will provide the required 3,700
additional interviews by December 1997. To maintain the study
organization during the 8 month review of the Modifiers Study, we will
support nurse interviewing with limited non-federal funds.
The long-term goal of the proposed study is to identify more completely
the mechanisms by which triggering occurs, and thereby facilitate
identification of new means of prevention. Although most potential
triggering activities are unavoidable, triggering of acute Ml could be
prevented by using drugs or other interventions to sever the
physiologic link between potential triggers and their catastrophic
consequences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358467
-
项目类别:
-
资助金额:$46.48万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358468
-
项目类别:
-
资助金额:$39.66万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
-
批准号:2219857
-
项目类别:
-
资助金额:$45.11万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358466
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
-
批准号:2219856
-
项目类别:
-
资助金额:$45.79万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
TRIGGERS OF VENTRICULAR ARRHYTHMIAS (TOVA) STUDY
-
批准号:6182326
-
项目类别:
-
资助金额:$51.36万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
TRIGGERS OF VENTRICULAR ARRHYTHMIAS (TOVA) STUDY
-
批准号:6389071
-
项目类别:
-
资助金额:$52.08万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
TRIGGERS OF VENTRICULAR ARRHYTHMIAS (TOVA) STUDY
-
批准号:2849665
-
项目类别:
-
资助金额:$54.27万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358469
-
项目类别:
-
资助金额:$47.41万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
-
批准号:2028400
-
项目类别:
-
资助金额:$49.22万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358464
-
项目类别:
-
资助金额:$38.55万
-
财政年份:1989
-
负责人:JAMES E MULLER
-
依托单位:
CIRCADIAN VARIATION IN COAGULABILITY AND ITS MODIFICATION
-
批准号:3950823
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
EFFECT OF NADOLOL ON THE CIRCADIAN VARIABILITY OF PLATELET AGGREGATION
-
批准号:3907514
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
EFFECT OF CAPTOPRIL ON THE MORNING INCREASE OF PLATELET AGGREGABILITY
-
批准号:3907515
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
EFFECT OF PN200-110 ON THE MORNING INCREASE OF COAGULABILITY
-
批准号:3888093
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
COMPARISON OF BETAXOLOL & ATENOLOL ON RESPONSE TO MENTAL & PHYS. STRESS
-
批准号:3866974
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
RAPIDITY & DURATION OF SUPPRESSION OF PLATELET AGGREGABILITY BY ECOTRIN
-
批准号:3852375
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
BETAXOLOL & ATENOLOL COMPARISON OF RESPONSE TO MENTAL/PHYSICAL STRESS
-
批准号:3852358
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
BETAXOLOL VERSUS ATENOLOL--EFFECTS ON RESPONSE TO MENTAL AND PHYSICAL STRESS
-
批准号:3788770
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
POSSIBLE CIRCADIAN VARIATION IN COAGULABILITY
-
批准号:3928359
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Aspirin调控AKT/Foxo3a/BIM通路延缓吡咯替尼耐药作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:田武国
-
依托单位:
Aspirin与自噬通路及核转录因子FoxG1在听觉系统退行性变中的协同调控机制研究
-
批准号:81800915
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:贺祖宏
-
依托单位:
Aspirin联合牙周膜干细胞再生全脱位牙牙周组织机制研究
-
批准号:81760190
-
项目类别:地区科学基金项目
-
资助金额:32.0万元
-
批准年份:2017
-
负责人:王璇
-
依托单位:
可注射温敏型水凝胶缓释Aspirin碳点和EPO促牙周组织再生的研究
-
批准号:81600879
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:徐晓薇
-
依托单位:
Aspirin协同IFN-α抑制肝癌转移复发的作用及机制研究
-
批准号:30972889
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:智绪亭
-
依托单位:
胃癌microRNA特异表达与靶基因调控及Aspirin的作用
-
批准号:30873099
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2008
-
负责人:王雪融
-
依托单位: